รายงานผลงานวิจัย และงานสร้างสรรค์ที่นาไปใช้ประโยชน์ระดับนานาชาติในปีปฏิทิน 2556

ลาดับ

ชื่อผลงานวิจัย

ผู้วิจัยหลัก

ผู้วิจัยร่วม

ข้อมูลการตีพิมพ์

1

Effects of sodium acetate and sucrose on in vitro alkaloid production from Stemona sp. Culture

Dheeranupattana, S

Chaichana, N

Asian Journal of Plant Sciences Volume 12, Issue 2, 2013, Pages 92-96

2

Proteomic profiling of stemona alkaloids production response to Chitosan elicitor

Dheeranupattana, S.a

Sangthong, P.b, Roytrakul, S.c, Chaichana, N.a

Pakistan Journal of Biological Sciences Volume 16, Issue 18, 2013, Pages 950-954

3

Switching HIV Treatment in Adults Based on CD4 Count Versus Viral Load Monitoring: A Randomized, Non-Inferiority Trial in Thailand

Jourdain, G.abc

Chaichana, N

PLoS Medicine Volume 10, Issue 8, August 2013, Article numbere1001494

4

Cultural considerations in family therapy: Boys with conversion

Trangkasombat, U.

Asian Biomedicine Volume 7, Issue 1, February 2013, Pages 131-136

5

Time to relapse and remission of bipolar disorder: Findings from a 1-year prospective study in Thailand

Leelahanaj, T.

Tangwongchai, S

Neuropsychiatric Disease and Treatment Volume 9, 21 August 2013, Pages 1249-1256

6

Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from a clinical - consensus to scientific diagnosis

Morris G

Maes M.

Neuro-Endocrinol Lett.2013;34(3):185-199.

7

Coenzyme Q10 depletion in medical and neuropsychiatric disorders, including Myalgic Encephalomyelitis / chronic fatigue syndrome,

Morris G

Anderson G, Berk M, Maes M.

Mol. Neurobiol. 2013; Jun 13. [Epub ahead of print] PubMed PMID: 23761046.

8

The emerging role of autoimmunity in Myalgic Encephalomyelitis / chronic fatigue syndrome

Morris G

Berk M, Galecki P, Maes M.

Mol Neurobiol. 2013; DOI: 10.1007/s12035-013-8553-0.

9

Clinical predictors of 2-year outcome of resective epilepsy surgery in adults with refractory epilepsy: a cohort study.

Kanchanatawan B

Limothai C, Srikijvilaikul T, Maes M.

BMJ Open. 2014 Apr 22;4(4):e004852. doi: 10.1136/bmjopen-2014-004852

10

Development and validation of the Menopause-specific Quality of Life Scale for menopausal Thai women.

Chaikittisilpa S

Nimnuan C

Climacteric. 2013 Jun;16(3):387-92. doi: 10.3109/13697137.2012.707707. Epub 2012 Sep 27.

11

Inter-correlation of knowledge, attitude, and osteoporosis preventive behaviors in women around the age of peak bone mass.

Puttapitakpong P

Nimnuan C

BMC Womens Health. 2014 Mar 3;14(1):35. doi: 10.1186/1472-6874-14-35.

12

Level of agreement between self - rated and clinician - rated instruments when measuring major depressive disorder in the Thai elderly : a L-year assessment as part of the THAISAD study

Wongpakaran N, Wongpakaran T, Wannarit K, Saisavoey N, Pinyopornpanish M, Lueboonthavatchai P

Clin Interv Aging 2014; 9:377-82.

13

Randomized Controlled Trial of Group Cognitive Behavioural Therapy for Post-Traumatic Stress Disorder in Children and Adolescents Exposed to Tsunami in Thailand.

Pityaratstian N

Piyasil V

Behav Cogn Psychother. 2014 Apr 8:1-13. [Epub ahead of print]

14

Baseline characteristics of depressive disorders in Thai outpatients : findings from the Thai Study of Affective Disorders

Wongpakaran T, Wongpakaran N, Pinyopornpanish M, Srisutasanavong U, Lueboonthavatchai P, Nivataphand R

Neuropsychiatr Dis Treat 2014; 10:217-23.

15

Effects of Buddhism walking meditation on depression, functional fitness, and endothelium-dependent vasodilation in depressed elderly.

Prakhinkit S

Suppapitiporn S, Tanaka H, Suksom D.

J Altern Complement Med. 2014 May;20(5):411-6. doi: 10.1089/acm.2013.0205. Epub 2013 Dec 28.

16

Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders

Talarowska M, Bobińska K, Zajączkowska M, Su KP, Maes M, Gałecki P.

Med Sci Monit. 2014 Jan 24;20:110-5. doi:10.12659/MSM.889853. PubMed PMID: 24457625

17

Inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity reaction by antidepressant drugs

Curzytek K, Kubera M, Majewska-Szczepanik M, Szczepanik M, Marcińska K, Ptak W, Duda W, Leśkiewicz M, Basta-Kaim A, Budziszewska B, Lasoń W, Maes M.

Pharmacol Rep. 2013;65(5):1237-46. PubMed PMID: 24399719.

18

Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications. Curr Pharm Des

Anderson G, Maes M

2013 Oct 28. [Epub ahead of print] PubMed PMID: 24180395.

19

Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Anderson G, Berk M, Dean O, Moylan S, Maes M.

CNS Drugs. 2014 Jan;28(1):1-10. doi: 10.1007/s40263-013-0119-1. PubMed PMID: 24150993.

20

Neurodegeneration in Parkinson's Disease: Interactions of Oxidative Stress, Tryptophan Catabolites and Depression with Mitochondria and Sirtuins. Mol

Anderson G, Maes M.

2013 Oct 2. [Epub ahead of print] PubMed PMID: 24085563.

21

The Emerging Role of Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/cfs). Mol Neurobiol

Morris G, Berk M, Galecki P, Maes M.

2013 Sep 26. [Epub ahead of print] PubMed PMID: 24068616.

22

Reconceptualizing Adult Neurogenesis: Role for Sphingosine-1-Phosphate and Fibroblast Growth Factor-1 in Co-ordinating Astrocyte-Neuronal Precursor Interactions. CNS Neurol Disord Drug Targets

Anderson G, Maes M.

2013 Sep 16. [Epub ahead of print] PubMed PMID: 24040808.

23

Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome

Anderson, G., Berk, M., Maes, M.

(2014) Acta Psychiatrica Scandinavica, 129 (2), pp. 83-97. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0 84891834559&partnerID=40&md5=27de81d0b2efb1706701fed6c1d1249f

24

A topic disorders and depression: Findings from a large, population-based study

Maes, M., O'Neil, A., Girardi, P., Williams, L. J.

(2014 )Journal of Affective Disorders, 155 (1), pp. 261-265

25

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: Potential repercussions and therapeutic implications (2013) Molecular Neurobiology, 48 (3), pp. 883-903.

Morris, G., Anderson, G., Berk, M., Maes, M.

(2013) Molecular Neurobiology, 48 (3), pp. 883-903.

26

A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome

Morris, G., Maes, M.

(2013) Metabolic Brain Disease, 28 (4), pp. 523-540. Cited 3 times.

27

Case definitions and diagnostic criteria for myalgic encephalomyelitis and chronic fatigue syndrome: From clinicalconsensus to evidence-based case definitions

Morris, G., Maes, M.

(2013) Activitas Nervosa Superior Rediviva, 55 (1-2), pp. 64-78.

28

Inhibitory effect of antidepressants on B16F10 melanoma tumor growth

Grygier, B., Arteta, B., Kubera, M., Basta-Kaim, A., Budziszewska, B., Leśkiewicz, M., Curzytek, K., Duda, W., Lasoń, W., Maes, M.

(2013) Pharmacological Reports, 65 (3), pp. 672-681.

29

Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts

Bortolasci, C.C., Barbosa, D.S., Morimoto, H.K., Venugopal, K., Doddd, S., Maes, M., Berk, M.

(2013) Journal of Affective Disorders, 150 (3), pp. 923-930. Cited 1 time.

30

Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics

Morris, G., Maes, M.

(2013) BMC Medicine, 11 (1), art. no. 205

31

Mitochondrial dysfunctions in Myalgic Encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways

Morris, G., Maes, M.

(2013) Metabolic Brain Disease, pp. 1-18. Article in Press.

32

In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation

Maes, M., Ringel, K., Kubera, M., Anderson, G., Morris, G., Galecki, P., Geffard, M.

(2013) Journal of Affective Disorders, 150 (2), pp. 223-230. Cited 1 time.

33

Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome

Maes, M.

(2013) Modern Trends in Pharmacopsychiatry, 28, pp. 162-174.

34

Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development

Gałecki, P., Gałecka, E., Maes, M., Orzechowska, A., Berent, D., Talarowska, M., Bobińska, K., Lewiński, A., Bieńkiewicz, M.,

(2013) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 45, pp. 117-124.

35

Role of the toll like receptor (TLR) radical cycle in chronic inflammation: Possible treatments targeting the TLR4 pathway

Lucas, K., Maes, M.

(2013) Molecular Neurobiology, 48 (1), pp. 190-204. Cited 5 times.

36

A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4months

Kubera, M., Curzytek, K., Duda, W., Leskiewicz, M., Basta-Kaim, A., Budziszewska, B., Roman, A., Zajicova, A., Holan, V.,

(2013) Brain, Behavior, and Immunity, 31, pp. 96-104. Cited 3 times.

37

Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression

Maes, M., Kubera, M., Mihaylova, I., Geffard, M., Galecki, P., Leunis, J.-C., Berk, M.

(2013) Journal of Affective Disorders, 149 (1-3), pp. 23-29.

38

Case definitions and diagnostic criteria for myalgic encephalomyelitis and chronic fatigue syndrome: From clinical-consensus to evidence-based case definitions

Morris, G., Maes, M.

(2013) Neuroendocrinology Letters, 34 (3), pp. 185-199. Cited 1 time.

39

Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours

Moylan, S., Eyre, H.A., Maes, M., Baune, B.T., Jacka, F.N., Berk, M.

(2013) Neuroscience and Biobehavioral Reviews, 37 (4), pp. 573-584. Cited 3 times.

40

Diagnosis of myalgic encephalomyelitis: Where are we now?

Maes, M., Anderson, G., Morris, G., Berk, M.

(2013) Expert Opinion on Medical Diagnostics, 7 (3), pp. 221-225. Cited 3 times.

41

So depression is an inflammatory disease, but where does the inflammation come from? (2013) BMC Medicine, 11 (1), art. no. 200, .

Berk, M., Williams, L.J., Jacka, F.N., O'Neil, A., Pasco, J.A., Moylan, S., Allen, N.B., Stuart, A.L., Hayley, A.C., Byrne, M.L.,

(2013) BMC Medicine, 11 (1), art. no. 200

42

The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications

Moylan, S., Maes, M., Wray, N.R., Berk, M.

(2013) Molecular Psychiatry, 18 (5), pp. 595-606. Cited 15 times.

43

In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes

Maes, M., Kubera, M., Leunis, J.-C., Berk, M., Geffard, M., Bosmans, E.

(2013) Acta Psychiatrica Scandinavica, 127 (5), pp. 344-354. Cited 5 times.

44

Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder

Gałecki, P., Orzechowska, A., Berent, D., Talarowska, M., Bobińska, K., Gałecka, E., Lewiński, A., Maes, M.,

(2013) Journal of Affective Disorders, 147 (1-3), pp. 144-149. Cited 1 time.

45

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways

Anderson, G., Maes, M., Berk, M.

(2013) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 42, pp. 101-114. Cited 8 times.

46

Putative neuroprotective agents in neuropsychiatric disorders

Dodd, S., Maes, M., Anderson, G., Dean, O.M., Moylan, S., Berk, M.

(2013) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 42, pp. 135-145. Cited 4 times.

47

Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression

Anderson, G., Maes, M.

(2013) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 42, pp. 5-19. Cited 10 times.

48

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

Anderson, G., Berk, M., Dodd, S., Bechter, K., Altamura, A.C., Dell'Osso, B., Kanba, S., Monji, A., Fatemi, S.H., Buckley, P.,

(2013) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 42, pp. 1-4. Cited 11 times.

49

Aspirin: A review of its neurobiological properties and therapeutic potential for mental illness

Berk, M., Dean, O., Drexhage, H., McNeil, J.J., Moylan, S., O'Neil, A., Davey, C.G., Sanna, L., Maes, M.

(2013) BMC Medicine, 11 (1), art. no. 74, pp. 1-17. Cited 5 times.

50

A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior

Morris, G., Anderson, G., Galecki, P., Berk, M., Maes, M.

(2013) BMC Medicine, 11 (1), art. no. 64, pp. 1-19. Cited 2 times.

51

Postpartum depression: Psychoneuroimmunological underpinnings and treatment

Anderson, G., Maes, M.

(2013) Neuropsychiatric Disease and Treatment, 9, pp. 277-287.

52

Metabolic Syndrome, Alzheimer’s, Schizophrenia and Depression: role for leptin, melatonin, tryptophan catabolite pathway and neuropeptides.Metabolic Syndrome and Neurological Disorders

Anderson G, Maes M.

2013. John Wiley & Sons, Inc. Published Online: 11 Oct 2013. DOI:

53

Invited Review: Increased interleukin 6 trans-signalling in depression.

Anderson G, Kubera M, Berk M, Maes M.

Pharmacol Rep. 2013;65:1647-1654.

54

Crosstalk between contact hypersensitivity reaction and antidepressant drugs.Pharmacol Reports. 2013;65:1673-1680.

Curzytek K, Kubera M, Szczepanik M, Basta-Kaim A, Budziszewska B, Lasoń W, Maes M.

Pharmacol Reports. 2013;65:1673-1680.

55

Melatonin in the Etiology, Pathophysiology, and Management of Schizophrenia. In: Melatonin and Melatonergic Drugs in Clinical Practice

Anderson G, Maes M.

Editors: V. Srinivasan, Amnon Brzezinski, Sukru Oter, Samuel D. Shillcutt; Springer, 2014, pp 307-320.

56

Invited Review: How the findings about inflammatory imbalances can be translated in new and better treatments for major depression? In SI: Immunology of Psychiatric Disorders

Noto C, Rizzo LB, Mansur RB, McIntyre RS, Maes M, Brietke E.

(Edited by A.L.Taxeira and N.Muller).Neuroimmunomodulation. 2014;21(2-3):131-139.

57

MnSOD gene expression and cognitive function in recurrent depressive disorder

Talarowska M, Orzechowska A, Szemraj J, Maes M, Galecki P.

Neuropsychobiology. 2013,in press.

58

Introduction to the Special Issue: New trends in neurobiology and pharmacology of affective disorders.

Lasoń W, Basta-Kaim A, Kubera M, Maes M.

Pharmacology Reports. 2013;65(6):1441-1450.

59

Invited Review: Targeting classical interleukin-6 (IL-6) signalling ot IL-6 trans-signalling in depression.Expert Opin Ther Targets, 2014;February 19.

. Maes M, Anderson G, Kubera M, Berk M.

Expert Opin Ther Targets, 2014;February 19.

60

Molecular mechanisms underpinning laser printer and photocopier induced symptoms, including chronic fatigue syndrome and respiratory tract hyperresponsiveness: pharmacological treatment with Cinnamon and Hydrogen.

Lucas K, Maes M.

Neuro-Endocrinology Letters. 2013;34(8)723-737.

61

Characteristics of the metabolic syndrome in unipolar and bipolar depression Life Sciences

Bortolasci CC, Barbosa DS, Venugopal K, Dodd S, Venugopal K, Maes M, Berk M.

2013;online 6 March.

62

Lowered plasma paraoxonase (PON)1 activity is a trait marker of unipolar depression and PONQ192R gene – smoking interactions predict the odds of unipolar and bipolar disorder differently J Affect Disord

Vargas HO, Vargas Nunes SO, Pizzo de Castro M, Bortolasci CC, Barbosa DS, Venugopal K, Dodd S, Venugopal K, Berk M, Maes M.

2013;online publication.